These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 18703252

  • 1. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G.
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [Abstract] [Full Text] [Related]

  • 2. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C.
    Circulation; 2008 Apr 15; 117(15):1945-54. PubMed ID: 18378618
    [Abstract] [Full Text] [Related]

  • 3. Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study.
    Khalangot M, Tronko M, Kravchenko V, Kovtun V.
    Diabetes Res Clin Pract; 2009 Dec 15; 86(3):247-53. PubMed ID: 19796836
    [Abstract] [Full Text] [Related]

  • 4. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine.
    Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G.
    Heart; 2009 Mar 15; 95(6):454-60. PubMed ID: 18697804
    [Abstract] [Full Text] [Related]

  • 5. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study.
    Gulliford M, Latinovic R.
    Diabetes Metab Res Rev; 2004 Mar 15; 20(3):239-45. PubMed ID: 15133756
    [Abstract] [Full Text] [Related]

  • 6. Cause-specific mortality in insulin-treated diabetic patients: a 20-year follow-up.
    Dawson SI, Willis J, Florkowski CM, Scott RS.
    Diabetes Res Clin Pract; 2008 Apr 15; 80(1):16-23. PubMed ID: 18329124
    [Abstract] [Full Text] [Related]

  • 7. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.
    Diabetes Care; 2007 Feb 15; 30(2):292-9. PubMed ID: 17259497
    [Abstract] [Full Text] [Related]

  • 8. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M, Amini M.
    Ophthalmic Epidemiol; 2004 Dec 15; 11(5):347-58. PubMed ID: 15590582
    [Abstract] [Full Text] [Related]

  • 9. Statin use in Type 2 diabetes mellitus is associated with a delay in starting insulin.
    Yee A, Majumdar SR, Simpson SH, McAlister FA, Tsuyuki RT, Johnson JA.
    Diabet Med; 2004 Sep 15; 21(9):962-7. PubMed ID: 15317599
    [Abstract] [Full Text] [Related]

  • 10. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus.
    Bruno G, Merletti F, Boffetta P, Cavallo-Perin P, Bargero G, Gallone G, Pagano G.
    Diabetologia; 1999 Mar 15; 42(3):297-301. PubMed ID: 10096781
    [Abstract] [Full Text] [Related]

  • 11. Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes.
    Hu G, Eriksson J, Barengo NC, Lakka TA, Valle TT, Nissinen A, Jousilahti P, Tuomilehto J.
    Circulation; 2004 Aug 10; 110(6):666-73. PubMed ID: 15277321
    [Abstract] [Full Text] [Related]

  • 12. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.
    Pharmacoepidemiol Drug Saf; 2003 Mar 10; 12(2):121-7. PubMed ID: 12642975
    [Abstract] [Full Text] [Related]

  • 13. Insulin restriction and associated morbidity and mortality in women with type 1 diabetes.
    Goebel-Fabbri AE, Fikkan J, Franko DL, Pearson K, Anderson BJ, Weinger K.
    Diabetes Care; 2008 Mar 10; 31(3):415-9. PubMed ID: 18070998
    [Abstract] [Full Text] [Related]

  • 14. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.
    Simpson SH, Majumdar SR, Tsuyuki RT, Eurich DT, Johnson JA.
    CMAJ; 2006 Jan 17; 174(2):169-74. PubMed ID: 16415461
    [Abstract] [Full Text] [Related]

  • 15. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
    Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT.
    J Clin Oncol; 2012 Jan 01; 30(1):53-9. PubMed ID: 22124092
    [Abstract] [Full Text] [Related]

  • 16. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.
    Smooke S, Horwich TB, Fonarow GC.
    Am Heart J; 2005 Jan 01; 149(1):168-74. PubMed ID: 15660049
    [Abstract] [Full Text] [Related]

  • 17. All-cause mortality in insulin-treated diabetic patients: a 20-year follow-up.
    Dawson SI, Willis J, Florkowski CM, Scott RS.
    Diabetes Res Clin Pract; 2008 Apr 01; 80(1):e6-9. PubMed ID: 18329123
    [Abstract] [Full Text] [Related]

  • 18. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM, Klotsche J, Hamnvik OP, Sievers C, Pieper L, Wittchen HU, Stalla GK, Schmid RM, Kales SN, Mantzoros CS.
    Metabolism; 2011 Oct 01; 60(10):1363-71. PubMed ID: 21081242
    [Abstract] [Full Text] [Related]

  • 19. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
    Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L, DIGAMI 2 Investigators.
    Eur Heart J; 2008 Jan 01; 29(2):166-76. PubMed ID: 18156614
    [Abstract] [Full Text] [Related]

  • 20. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Nilsson PM, Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Fagard R, Gudbjörnsdóttir S, Swedish National Diabetes Register.
    Eur J Cardiovasc Prev Rehabil; 2009 Aug 01; 16(4):506-12. PubMed ID: 19561510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.